Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...
The comprehensive review Michael Alford promised when FSU announced it would retain Mike Norvell is now in full swing. Here's ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation ...
Structure Therapeutics (GPCR) announced positive topline data from the ACCESS clinical program of aleniglipron for the treatment of people living ...
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
Investing.com -- Structure Therapeutics Inc ADR (NASDAQ:GPCR) stock soared 28.8% in premarket trading Monday after the company announced positive topline data from its ACCESS clinical program for ...
Long the titan of prep schools in Los Angeles, with a reputation as an Ivy League feeder, Harvard-Westlake has seen the ...
A new vision for passenger rail is on track in southeastern Wisconsin. The Milwaukee Area-Racine-Kenosha Passenger Rail has ...
The Vicksburg Police Department officially launched its new U-Turn youth diversion program this week, drawing what Deputy ...
This edition of the NCAA 2025-26 women's college basketball season's power rankings covers expected dominance and unexpected ...
Global player Allianz is partnering with investor Oaktree Capital Management to launch a reinsurance syndicate in the Lloyd's ...
NRMLA sent HUD and FHA a detailed letter urging lower upfront MIP, HMBS index changes and new liquidity options for reverse mortgages.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback